Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls

Rheumatology International

Volumn 33, Issue 8, 2013, Pages 2031-2038

  Robeva, Ralitsa ^a   Tanev, Dobromir ^a   Andonova, Silvia ^a   Kirilov, Georgi ^a   Savov, Alexey ^a   Stoycheva, Milena ^a   Tomova, Analia ^a   Kumanov, Philip ^a   Rashkov, Rasho ^a   Kolarov, Zlatimir ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Androgen receptor CAG polymorphism; Autoimmunity; SLE

Indexed keywords

ANDROGEN RECEPTOR; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ALLELE; ANDROGEN BLOOD LEVEL; ARTICLE; CAG REPEAT; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; ANDROGENS; FEMALE; GENE FREQUENCY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANDROGEN;

EID: 84880922512     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2687-2     Document Type: Article

References (37)

1. Cervera R, Espinosa G, D'Cruz D (2009) Systemic lupus erythematosus: pathogenesis, clinical manifestations and diagnosis. In: Bijlsma JW (ed) EULAR compendium on rheumatic diseases. BMJ Publishing Group and European League Against Rheumatism, London, pp 257-268
2. Cutolo M, Sulli A, Capellino S et al (2004) Sex hormones influence on the immune system: basic and clinical aspects of autoimmunity. Lupus 13:635-638
3. Kanda N, Tsuchida T, Tamaki K (1997) Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 40:1703-1711
4. Walker SE, Besch-Williford CL, Keisler DH (1994) Accelerated deaths from systemic lupus erythematosus in NZB × NZW F1 mice treated with the testosterone-blocking drug flutamide. J Lab Clin Med 124:401-407
5. Palazzolo I, Gliozzi A, Rusmini P et al (2008) The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol 108:245-253
6. Simanainen U, Brogley M, Gao YR et al (2011) Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol 342:81-86
7. La Spada AP, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
8. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
9. Stoll T, Seifert B, Isenberg DA (1996) SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35:248-254
10. Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients, The committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
12. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
13. Lyon MF (1988) The William Allan memorial award address: X-chromosome inactivation and the location and expression of X-linked genes. Am J Hum Genet 42:8-16
14. Hickey T, Chandy A, Norman RJ (2002) The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 87:161-165
15. Westberg L, Baghaei F, Rosmond R et al (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562-2568
16. Fehér KG, Bencze G, Ujfalussy J, Fehér T (1987) Serum steroid hormone levels in systemic lupus erythematosus (SLE). Acta Med Hung 44:321-327
17. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30:241-248
18. Folomeev M, Dougados M, Beaune J et al (1992) Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1:191-195
19. Navarro MA, Vidaller A, Ortolá JB, Bonnin MR, Pac MV, Moga I (1992) Salivary testosterone levels in women with systemic lupus erythematosus. Arthritis Rheum 35:557-559
20. Muñoz JA, Gil A, López-Dupla JM, Vázquez JJ, González-Gancedo P (1994) Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters. Ann Med Interne (Paris) 145:459-463
21. Speroff L, Fritz M (2005) Hormone biosynthesis, metabolism and mechanism of action. In: Fritz M, Speroff L (eds) Clinical gynecologic endocrinology and infertility. Lippincot Williams & Willkins, Philadelphia, pp 25-96
22. Rizzo L, Dobrovsky V, Danilowicz K et al (2007) Low-dose glucocorticoids in hyperandrogenism. Medicina (B Aires) 67:247-252
23. Huhtaniemi IT, Pye SR, Limer KL et al European Male Ageing Study Group (2009) Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 94:277-284
24. Jääskeläinen J, Korhonen S, Kuulasmaa T et al (2008) Androgen receptor gene CAG repeat length in women with metabolic syndrome. Gynecol Endocrinol 24:411-416
25. Brum IS, Spritzer PM, Paris F, Maturana MA, Audran F, Sultan C (2005) Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. J Soc Gynecol Investig 12:135-141
26. Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY (2008) Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril 90:2318-2323
27. Van Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De Sutter P (2008) Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome. Gynecol Endocrinol 24:669-673
28. Nenonen H, Björk C, Skjaerpe PA, Giwercman A, Rylander L, Svartberg J, Giwercman YL (2010) CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 16:153-157
29. Davis-Dao C, Koh CJ, Hardy BE, Chang A et al (2012) Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab 97:E393-E399
30. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM (2003) The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 176:293-304
31. Rahman F, Christian HC (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18:371-378
32. Tessnow AH, Olsen NJ, Kovacs WJ (2011) Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus. J Clin Immunol 31:567-573
33. Deng Y, Grossman JM, Fu Q et al (2011) Association of androgen receptor gene polymorphism with damage in systemic lupus erythematosus. In: ACR/ARHP annual scientific meeting 11 (abstract 640)
34. Saltiki K, Cimponeriu A, Garofalaki M et al (2011) Severity of coronary artery disease in postmenopausal women: association with the androgen receptor gene (CAG)n repeat polymorphism. Menopause 18:1225-1231
35. Zitzmann M, Brune M, Kornmann B et al (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867-4873
36. Pausova Z, Abrahamowicz M, Mahboubi A et al (2010) Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 55:706-714
37. Kuliczkowski W, Filus A, Kuliczkowska-Plaksej J et al (2010) Androgen receptor polymorphism and platelet reactivity in healthy men. Thromb Res 126:65-67